Krishnan Viswanadhan
Director/Board Member at CARGO THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Profile
Krishnan Viswanadhan is currently the Director at JW Therapeutics (Shanghai) Co., Ltd.
He is also an Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., an Independent Director at Cargo Therapeutics, Inc., and the President & Chief Operating Officer at Be Biopharma, Inc. Previously, he worked as the Vice President-Business Development at Celgene Corp.
and as a Program Manager at F.
Hoffmann-La Roche Ltd.
Dr. Viswanadhan holds an undergraduate and doctorate degree from Rutgers State University of New Jersey and an MBA from Cornell University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 2024-04-04 | 0 ( -.--% ) | - $ | 2024-04-29 |
Krishnan Viswanadhan active positions
Companies | Position | Start |
---|---|---|
CARGO THERAPEUTICS, INC. | Director/Board Member | 2022-09-30 |
JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 2019-11-19 |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | President | 2021-06-30 |
Former positions of Krishnan Viswanadhan
Companies | Position | End |
---|---|---|
CELGENE | Corporate Officer/Principal | 2019-07-31 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Training of Krishnan Viswanadhan
Rutgers State University of New Jersey | Doctorate Degree |
Cornell University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
CARGO THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Krishnan Viswanadhan